Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT02276950

HeAlth-data Register sTudies of Risk and Outcomes in Cardiac Surgery

HeAlth-data Register sTudies of Risk and Outcomes in Cardiac Surgery (HARTROCS)

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
150,000 (estimated)
Sponsor
Ulrik Sartipy, MD, PhD · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The overall project aim is to study risk and outcomes following cardiac surgery by cross-linking high-quality national Swedish health-data registers for population-based investigations of individual level clinically relevant patient data.

Detailed description

The purpose of this research project is to study risks and outcomes in patients who underwent cardiac surgery. We aim to establish a fundament for the conduct of nationwide population-based studies by linking patient-level data from the Swedish Heart Surgery Register (SWEDEHEART), the National Patient Register, the Cause of Death Register, the National Diabetes Register, the Swedish Renal Registry, the Prescribed Drug Register, and the 2nd version of the Swedish-Danish Scandinavian Donations and Transfusions database. Cross-linking patient-level data is possible through the Personal Identity Number assigned to every individual who has resided in Sweden on a permanent basis. The Swedish Personal Identity Number is the unique identifier in all national registers. Specifically, we aim: 1. To assess the importance of chronic kidney disease for prognosis after CABG. 2. To assess the consequences of acute kidney injury following CABG. 3. To analyze the prognosis in patients with depression prior to CABG. 4. To study risks and benefits of blood transfusions in cardiac surgery. 5. To study the risks associated with diabetes mellitus in cardiac surgery with special reference to type of diabetes (type 1 and type 2) and glycaemic control and duration of disease. 6. To investigate the long-term impact of different surgical strategies (e.g. use of multiple arterial grafts or non-use of cardio-pulmonary bypass) during CABG. 7. To analyze prognosis in relevant sub-populations undergoing CABG (e.g. patients 50 years or younger, possible differences between men and women, and patients with heart failure with preserved vs. reduced ejection fraction). 8. To investigate survival and morbidity in patients between 50 and 69 years undergoing aortic valve replacement with particular reference to prosthesis type (mechanical vs. biological). 9. To analyze the association between socioeconomic factors and prognosis in patients undergoing cardiac surgery. 10. To investigate factors related to durability of bioprosthetic aortic heart valves.

Conditions

Interventions

TypeNameDescription
PROCEDURECoronary artery bypass surgeryPrimary isolated coronary artery bypass surgery with or without use of cardio-pulmonary bypass
PROCEDUREHeart valve surgeryHeart valve surgery, aortic valve replacement or other heart valve procedures

Timeline

Start date
2011-01-01
Primary completion
2026-12-01
Completion
2027-12-01
First posted
2014-10-28
Last updated
2024-10-08

Source: ClinicalTrials.gov record NCT02276950. Inclusion in this directory is not an endorsement.